DEUTSCHE BANK AG\ - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 44 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2016$02,0000.0%0.00%
Q2 2016$02,0000.0%0.00%
Q1 2016$02,0000.0%0.00%
Q4 2015$0
-100.0%
2,000
-78.9%
0.00%
Q3 2015$5,0000.0%9,5000.0%0.00%
Q2 2015$5,000
-28.6%
9,5000.0%0.00%
Q1 2015$7,000
-56.2%
9,500
-55.0%
0.00%
Q4 2014$16,000
+77.8%
21,100
+122.1%
0.00%
Q3 2014$9,000
-25.0%
9,500
-34.5%
0.00%
Q2 2014$12,00014,5000.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q4 2015
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$6,0000.00%
LEE DANNER & BASS INC 50,000$3,0000.00%
Ancora Advisors LLC 14,650$1,0000.00%
Diversified Trust Co 50,000$3,0000.00%
CAPTRUST FINANCIAL ADVISORS 57,659$3,0000.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders